Asia Healthcare Holdings owned Nova IVF Fertility, which is a fertility chain has announced the expansion of their network in NCR through strategic partnership with Southend Fertility & IVF.
Through this investment, Nova IVF Fertility will have a majority stake in Southend Fertility & IVF. The combined entity will have a significant presence in Delhi NCR with a network of 4 comprehensive IVF centres including embryology labs, network of spoke centres, a team of senior IVF clinicians and a capacity to perform more than 3500 IVF cycles annually in that region.
On the announcement of this strategic partnership, Mr. Shobhit Agarwal, CEO, Nova IVF Fertility, said, “Nova IVF has delivered over 35000 IVF pregnancies and within our network, we have some of the leading and most experienced IVF clinicians of the country. Our protocols in IVF have more than a decade of science behind them which contributes to our excellent success rate and parenthood to couples across the country. We welcome Southend Fertility & IVF to the Nova family and together this partnership will further strengthen the quality of IVF treatment available to patients in Delhi NCR”.
Commenting on the partnership, Dr. Sonia Malik, Founder & Lead IVF Specialist & Sameer Malik, CEO, Southend Fertility & IVF said, “India’s declining fertility rate is a cause of concern and we have to accelerate the expansion and reach of fertility-enhancing services to a larger section of couples in the country. Our partnership with Nova IVF is a merger of common ethos and respect for the science of IVF. Together we see new opportunities of expansion and delivering high-quality IVF treatment.”
“Advancements in IVF over the last decade has evolved with more precision and personalized treatment. Development in egg freezing, embryo transfers, Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) are serving as a boon to couples and helping couples have healthy babies. IVF treatment has evolved to treat fertility both in men and women such as endometriosis, male factor infertility, ovulatory dysfunctions, unexplained infertility and the rest,” a statement made by the company stated.
According to Mr. Vishal Bali, Executive Chairman, AHH, said, “At AHH we are focused on building single specialty healthcare delivery enterprises which are rooted with best-in-class clinical practices. Since our investment in Nova IVF the company has gone through a rapid transformation in its management team, footprint expansion within and outside India, clinical outcomes and unit economics. Nova’s legacy as a frontrunner in the IVF sector in India and its clinical differentiation is creating new opportunities of consolidation and partnerships with leading clinicians and enterprises in different regions of the country. Nova IVF and Southend Fertility coming together is a step in that direction which will deliver tremendous value to patients seeking IVF treatment in Delhi NCR. There are more such partnership’s under progress in the company.”
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.